In cancer cells, telomere length is maintained either through the activation of telomerase or alternative lengthening of telomeres (ALT), enabling their ceaseless proliferation; however, their telomeres are typically shorter than those in normal counterparts (Harley, 2008; Shay and Wright, 2019). The gene discussed is GPT; the disease is cancer.